Tonix Pharmaceuticals Holding Corp.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Checking your notes…
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TONIX PHARMACEUTICALS HOLDING CORP. | ||
| Date: March 12, 2026 | By: | /s/ SETH LEDERMAN |
|---|---|---|
| Seth Lederman | ||
| Chief Executive Officer (Principal Executive Officer) | ||
| Date: March 12, 2026 | By: | /s/ BRADLEY SAENGER |
| Bradley Saenger | ||
| Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Seth Lederman and Bradley Saenger, jointly and severally, his or her attorney-in-fact, with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Name | Position | Date |
|---|---|---|
| /s/ SETH LEDERMAN | Chief Executive Officer, President and Director (Principal Executive Officer) | March 12, 2026 |
| Seth Lederman | ||
| /s/ BRADLEY SAENGER | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | March 12, 2026 |
| Bradley Saenger | ||
| /s/ RICHARD BAGGER | Director | March 12, 2026 |
| Richard Bagger | ||
| /s/ MARGARET SMITH BELL | Director | March 12, 2026 |
| Margaret Smith Bell | ||
| /s/ DAVID GRANGE | Director | March 12, 2026 |
| David Grange | ||
| /s/ JAMES HUNTER | Director | March 12, 2026 |
| James Hunter | ||
| /s/ ADEOYE OLUKOTUN | Director | March 12, 2026 |
| Adeoye Olukotun | ||
| /s/ NEWCOMB STILLWELL | Director | March 12, 2026 |
| Newcomb Stillwell | ||
| /s/ CAROLYN TAYLOR | Director | March 12, 2026 |
| Carolyn Taylor | ||
| /s/ JAMES TRECO | Director | March 12, 2026 |
| James Treco | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.